Recent developments indicate that Laboratory Corporation of America Holdings LH is experiencing dynamic progress across various areas of its operations. These include declaring dividends and reporting substantial quarterly results, surpassing estimates, and raising its 2024 EPS view. Further strategic initiatives have been unveiled by the company, such as the winning bid for select assets of Invitae and the acquisition of select assets of BioReference Health's Diagnostics Business. Other areas of expansion include collaborations with Hawthorne Effect and Baystate Health regarding diagnostic laboratory services. The company has also launched new tests, introduced a weight loss management portfolio, and held successful earnings calls. Yet there have been a few setback, such as insiders implementing sell strategies of company stocks and a decrease in short interest. Regardless, multiple acquisitions have been made of LH shares by investment firms like Chicago Capital LLC, Natixis Advisors LLC, and Cooke & Bieler LP.
Laboratory Corporation of America Holdings LH News Analytics from Wed, 27 Jul 2016 07:00:00 GMT to Sun, 08 Sep 2024 10:42:17 GMT - Rating 7 - Innovation 8 - Information 8 - Rumor 5
